发明名称 |
SUBSTITUTED PIPERIDINES CONTAINING A HETEROARYLAMIDE OR HETEROARYLPHENYL MOIETY |
摘要 |
The invention provides compounds of the formula (I) having PKA and PKB ki nase inhibiting compounds of the formula (I): GP 1 J T 2 J N 4 R N H (I) or salts, solvates, tautomers or N-oxides thereof, wherein (1) GP is a group GP 1: HET 2a a Q G (HNCO)f 7 (R )x N * (GP1) (2) GP is a group GP2: 10 (R )r O 2a a QG (CH2)w N V H N * (GP2) wherein HET is a monocyclic or bicyclic heter ocyclic group containing up to 4 heteroatom ring members; the ring V is a mo nocyclic or bicyclic heteroaryl group of 5 to 10 ring members; and J1, J2, R 4, R7, R10, Q2a, Ga, x, w and f are as defined in the claims
|
申请公布号 |
CA2672841(A1) |
申请公布日期 |
2008.06.26 |
申请号 |
CA20072672841 |
申请日期 |
2007.12.20 |
申请人 |
ASTEX THERAPEUTICS LTD;CANCER RESEARCH TECHNOLOGY LIMITED;ASTRAZENECA AB;THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL |
发明人 |
DA FONSECA MCHARDY, TATIANA FARIA;LUKE, RICHARD WILLIAM ARTHUR;MATUSIAK, ZBIGNIEW STANLEY;HAMLETT, CHRISTOPHER;MORRIS, JEFFREY JAMES;CARR, GREGORY RICHARD;SORE, HANNAH FIONA;CALDWELL, JOHN;COLLINS, IAN;WALKER, DAVID WINTER;VERDONK, MARINUS LEENDERT;CHEUNG, KWAI MING;WOODHEAD, STEVEN JOHN |
分类号 |
C07D487/04;A61K31/519;A61P35/00;C07D471/04;C07D473/34 |
主分类号 |
C07D487/04 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|